[fcb5af]: / literature / by_gene / IKBKB.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 32885355 10.1007/s10637-020-00996-1 2022 The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma. IKBKB
2 33640899 10.1038/s41392-021-00477-8 2022 TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. IKBKB
3 34114393 10.19852/j.cnki.jtcm.2021.03.004 2022 Dihydromyricetin promotes apoptosis, suppresses proliferation and tumor necrosis factor-α-mediated nuclear factor kappa-B activation in nasopharyngeal carcinoma CNE-2 cell. IKBKB
4 35525271 10.1016/j.jbc.2022.102012 2022 Mechanistic insights into the activation of the IKK kinase complex by the Kaposi's sarcoma herpes virus oncoprotein vFLIP. IKBKB
5 35641486 10.1038/s41419-022-04946-y 2022 Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure. IKBKB
6 32024820 10.1038/s41419-020-2294-6 2021 Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL). IKBKB
7 32473470 10.1016/j.cellimm.2020.104129 2021 Gain-of-function mutations in CARD11 promote enhanced aggregation and idiosyncratic signalosome assembly. IKBKB
8 32627230 10.1002/jat.4003 2021 Cantharidin-induced acute hepatotoxicity: the role of TNF-α, IKK-α, Bcl-2, Bax and caspase3. IKBKB
9 32682634 10.1016/j.jdermsci.2020.06.013 2021 Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients. IKBKB
10 32858764 10.1111/jcmm.15774 2021 IKKε and TBK1 in diffuse large B-cell lymphoma: A possible mechanism of action of an IKKε/TBK1 inhibitor to repress NF-κB and IL-10 signalling. IKBKB
11 32961552 10.1182/blood.2020007507 2021 Mutational landscape of gray zone lymphoma. IKBKB
12 33098696 10.1111/ejh.13540 2021 RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma. IKBKB
13 33176636 10.2174/0929867327666201111142307 2021 A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options. IKBKB
14 34132431 10.1002/ptr.7157 2021 Suppression of phosphoinositide 3-kinase/phosphoinositide-dependent kinase-1/serum and glucocorticoid-induced protein kinase pathway. IKBKB
15 34474146 10.1016/j.exphem.2021.08.010 2021 miRNA-223-3p modulates ibrutinib resistance through regulation of the CHUK/Nf-κb signaling pathway in mantle cell lymphoma. IKBKB
16 34521919 10.1038/s41598-021-97775-6 2021 KCTD15 deregulation is associated with alterations of the NF-κB signaling in both pathological and physiological model systems. IKBKB
17 30688264 10.4103/1673-5374.249226 2020 <i>Shuxuetong</i> injection protects cerebral microvascular endothelial cells against oxygen-glucose deprivation reperfusion. IKBKB
18 31324389 10.1016/j.prp.2019.152528 2020 Quantitative proteomics analysis of differentially expressed proteins in activated B-cell-like diffuse large B-cell lymphoma using quantitative proteomics. IKBKB
19 31497245 10.18632/oncotarget.27098 2020 Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma. IKBKB
20 31606621 10.1016/j.biopha.2019.109530 2020 Investigation of candidate molecular biomarkers for expression profile analysis of the Gene expression omnibus (GEO) in acute lymphocytic leukemia (ALL). IKBKB
21 32019925 10.1038/s41467-020-14502-x 2020 A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation. IKBKB
22 32286300 10.1038/s41467-020-15576-3 2020 Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics. IKBKB
23 29295643 10.1080/10428194.2017.1413186 2019 The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples. IKBKB
24 29367645 10.1038/s41419-017-0157-6 2019 CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma. IKBKB
25 30199532 10.1371/journal.pbio.2006347 2019 Transcriptional outcomes and kinetic patterning of gene expression in response to NF-κB activation. IKBKB
26 30335863 10.1371/journal.pone.0206014 2019 Oncogenic mutations in IKKβ function through global changes induced by K63-linked ubiquitination and result in autocrine stimulation. IKBKB
27 27840321 10.1016/j.freeradbiomed.2016.11.010 2018 Pro-apoptotic effects of lipid oxidation products: HNE at the crossroads of NF-κB pathway and anti-apoptotic Bcl-2. IKBKB
28 28587181 10.3390/nu9060561 2018 Chronic Inflammatory Diseases and Green Tea Polyphenols. IKBKB
29 28906487 10.1038/cddis.2017.442 2018 Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma. IKBKB
30 29194363 10.3390/ijms18122581 2018 The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling. IKBKB
31 29333957 10.1177/1533034617745761 2018 MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-κB Pathway. IKBKB
32 29649481 10.1016/j.bbrc.2018.04.057 2018 Role of IκB kinase β in regulating the remodeling of the CARMA1-Bcl10-MALT1 complex. IKBKB
33 29665857 10.1186/s12977-018-0415-4 2018 The HTLV-1 oncoprotein Tax is modified by the ubiquitin related modifier 1 (Urm1). IKBKB
34 30111412 10.7534/j.issn.1009-2137.2018.04.024 2018 [Effect of IKK2 Inhibitor LY2409881 on Diffuse Large B-Cell Lymphoma Cell Apoptosis and Its Mechanism]. IKBKB
35 27123832 10.1016/j.leukres.2016.04.012 2017 Identification of TBK1 and IKKε, the non-canonical IκB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes. IKBKB
36 27681433 10.1016/j.celrep.2016.08.080 2017 MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage. IKBKB
37 28689659 10.1016/j.molcel.2017.06.011 2017 Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity. IKBKB
38 28931678 10.1128/JVI.01170-17 2017 IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection. IKBKB
39 25748427 10.1371/journal.pone.0119363 2016 MALT1-ubiquitination triggers non-genomic NF-κB/IKK signaling upon platelet activation. IKBKB
40 26158216 10.18632/oncotarget.4106 2016 Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas. IKBKB
41 26209362 10.1016/j.ejphar.2015.07.046 2016 A natural xanthone increases catalase activity but decreases NF-kappa B and lipid peroxidation in U-937 and HepG2 cell lines. IKBKB
42 26247921 10.1002/jcp.25122 2016 Nuclear Translocation of p65 is Controlled by Sec6 via the Degradation of IκBα. IKBKB
43 26275874 10.1007/82_2015_479 2016 Roles of the NF-κB Pathway in B-Lymphocyte Biology. IKBKB
44 26525107 10.1038/ncomms9777 2016 The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling. IKBKB
45 26573110 10.3892/ijo.2015.3238 2016 Involvement of cyclic-nucleotide response element-binding family members in the radiation response of Ramos B lymphoma cells. IKBKB
46 26603838 10.1182/blood-2015-07-658781 2016 Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphoma. IKBKB
47 26647777 10.3892/ijo.2015.3247 2016 Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma. IKBKB
48 26740240 10.1038/srep18934 2016 Inhibition of Canonical NF-κB Signaling by a Small Molecule Targeting NEMO-Ubiquitin Interaction. IKBKB
49 26988706 10.1186/s13073-016-0280-5 2016 A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses. IKBKB
50 27070702 10.1016/j.ccell.2016.03.006 2016 Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma. IKBKB
51 24362528 10.1038/onc.2013.552 2015 HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains. IKBKB
52 24732096 10.4161/cc.28707 2015 BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response. IKBKB
53 24798348 10.1371/journal.pone.0095404 2015 A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma. IKBKB
54 24867235 10.1038/ncomms4898 2015 Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKε- and CYLD-dependent Bcl3 activation. IKBKB
55 25096806 10.3892/ijo.2014.2578 2015 Protein kinase C-associated kinase regulates NF-κB activation through inducing IKK activation. IKBKB
56 25187543 10.1128/JVI.01766-14 2015 Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65. IKBKB
57 25245034 10.1186/s12964-014-0049-7 2015 AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation. IKBKB
58 25280822 10.1016/j.jstrokecerebrovasdis.2014.05.032 2015 Anti-inflammatory and antiapoptotic effects of mesenchymal stem cells transplantation in rat brain with cerebral ischemia. IKBKB
59 25304104 10.1016/j.yexcr.2014.09.034 2015 Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signaling. IKBKB
60 25355930 10.1158/1078-0432.CCR-14-0384 2015 The novel IKK2 inhibitor LY2409881 potently synergizes with histone deacetylase inhibitors in preclinical models of lymphoma through the downregulation of NF-κB. IKBKB
61 25446254 10.1016/j.cellsig.2014.11.014 2015 TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways. IKBKB
62 25736755 10.1007/978-1-4939-2422-6_16 2015 Elucidating dynamic protein-protein interactions and ubiquitination in NF-κB signaling pathways. IKBKB
63 25987724 10.1084/jem.20142009 2015 Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia. IKBKB
64 26116531 10.1016/j.bbrc.2015.06.120 2015 Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes. IKBKB
65 23620411 10.1158/1078-0432.CCR-12-3258 2014 Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB. IKBKB
66 23886693 10.1016/j.imbio.2013.06.013 2014 Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages. IKBKB
67 23963361 10.1158/1535-7163.MCT-13-0239 2014 Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach. IKBKB
68 24239354 10.1016/j.celrep.2013.10.022 2014 Context-specific BAFF-R signaling by the NF-κB and PI3K pathways. IKBKB
69 24303085 10.1371/journal.pone.0082688 2014 Lupeol is one of active components in the extract of Chrysanthemum indicum Linne that inhibits LMP1-induced NF-κB activation. IKBKB
70 24352466 10.1128/JVI.03025-13 2014 Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis. IKBKB
71 24464015 10.1182/blood-2014-01-547943 2014 IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1. IKBKB
72 24825920 10.1126/scisignal.2004882 2014 T cell receptor signals to NF-κB are transmitted by a cytosolic p62-Bcl10-Malt1-IKK signalosome. IKBKB
73 25049379 10.1073/pnas.1411701111 2014 Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors. IKBKB
74 25107905 10.1074/jbc.M114.598763 2014 IκB kinase β (IKBKB) mutations in lymphomas that constitutively activate canonical nuclear factor κB (NFκB) signaling. IKBKB
75 22595758 10.1038/cdd.2012.54 2013 PIDDosome-independent tumor suppression by Caspase-2. IKBKB
76 22653339 10.1038/cdd.2012.67 2013 C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in β-cells. IKBKB
77 22653966 10.1158/1535-7163.MCT-12-0141 2013 Oxidative stress induced by curcumin promotes the death of cutaneous T-cell lymphoma (HuT-78) by disrupting the function of several molecular targets. IKBKB
78 22889356 10.3109/10428194.2012.720371 2013 Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts. IKBKB
79 23028875 10.1371/journal.pone.0045244 2013 Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling. IKBKB
80 23032187 10.1038/emboj.2012.241 2013 Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. IKBKB
81 23087406 10.4049/jimmunol.1102952 2013 Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells. IKBKB
82 23149938 10.1128/MCB.00850-12 2013 A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival. IKBKB
83 23278479 10.1111/imm.12035 2013 The combination of IκB kinase β inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells. IKBKB
84 23463379 10.1002/ijc.28148 2013 Ca2+/calmodulin-dependent kinase II contributes to inhibitor of nuclear factor-kappa B kinase complex activation in Helicobacter pylori infection. IKBKB
85 23632891 10.1182/blood-2012-12-470153 2013 Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphoma. IKBKB
86 23727036 10.1016/j.jaci.2013.04.047 2013 A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency. IKBKB
87 21375523 10.1111/j.1365-2141.2011.08591.x 2012 Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and Bim. IKBKB
88 21881048 10.1182/blood-2011-06-359166 2012 Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma. IKBKB
89 21951590 10.1111/j.1349-7006.2011.02110.x 2012 An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells. IKBKB
90 21987722 10.1158/0008-5472.CAN-11-1715 2012 IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. IKBKB
91 22099304 10.1016/j.molcel.2011.09.015 2012 Direct, noncatalytic mechanism of IKK inhibition by A20. IKBKB
92 22262057 10.1002/jcp.24057 2012 Inactivation of Bcl-2 through IκB kinase (IKK)-dependent phosphorylation mediates apoptosis upon exposure to 4-hydroxynonenal (HNE). IKBKB
93 22343828 10.1038/cmi.2011.59 2012 Regulation of NF-κB signaling by the A20 deubiquitinase. IKBKB
94 22361669 10.4161/auto.8.2.18763 2012 Autophagy prolongs survival after NFκB inhibition in B-cell lymphomas. IKBKB
95 22384180 10.1371/journal.pone.0032215 2012 Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6. IKBKB
96 22435562 10.1111/j.1600-065X.2012.01094.x 2012 Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis. IKBKB
97 22474286 10.1074/jbc.M111.291708 2012 Forkhead transcription factor FOXO3a protein activates nuclear factor κB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation. IKBKB
98 22713244 10.4161/cc.20859 2012 Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a. IKBKB
99 22715589 10.3727/096504012x13285365944292 2012 Targeted repression of overexpressed CD30 downregulates NF-kappaB and ERK1/2 pathway in Hodgkin lymphoma cell lines. IKBKB
100 22865346 10.1007/s13238-012-2047-0 2012 New insight into the oncogenic mechanism of the retroviral oncoprotein Tax. IKBKB